Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.40 |
| ▸ | FDPS | P14324 | 4/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10928634 | 0.88 | PLA2G4A (0.39) | LPAR3LPAR1LPAR2SMPD1FDPS | |
| SCHEMBL16697061 | 0.87 | LPAR3 (0.40) | LPAR3LPAR1LPAR2SMPD1FDPS | |
| SCHEMBL16697211 | 0.84 | FDPS (0.52) | SMPD1FDPSMMP1MMP2MMP3 | |
| SCHEMBL10928628 | 0.81 | FDPS (0.40) | SMPD1FDPSMMP1MMP2MMP3 | |
| SCHEMBL11799989 | 0.81 | FDPS (0.52) | LPAR3LPAR2SMPD1FDPSMMP1 | |
| SCHEMBL16697000 | 0.73 | LPAR3 (0.41) | LPAR3LPAR1LPAR2SMPD1FDPS | |
| SCHEMBL7804496 | 0.72 | LPAR3 (0.53) | LPAR3LPAR1LPAR2SMPD1FDPS | |
| SCHEMBL10908985 | 0.70 | LPAR3 (0.47) | LPAR3LPAR1LPAR2FDPSMMP1 | |
| SCHEMBL13924966 | 0.70 | SMPD1 (0.46) | LPAR3LPAR1LPAR2SMPD1FDPS | |
| SCHEMBL31514043 | 0.70 | LPAR3 (0.46) | LPAR3LPAR1LPAR2MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11466341-B2 | Extractant for rare earth extraction from aqueous phosphoric acid solutions and method of extraction | Commissariat á l'énergie atomique et aux énergies alternatives (FR) | 2022-10-11 | — | — | US | claimed |
| WO-2022117948-A1 | METHOD FOR SELECTIVELY RECOVERING RARE EARTH METALS AND URANIUM(VI) FROM AN AQUEOUS SOLUTION OF PHOSPHORIC ACID | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2022-06-09 | — | — | WO | claimed |
| US-20190218643-A1 | NEW EXTRACTANT, USEFUL FOR EXTRACTING RARE EARTHS FROM AN AQUEOUS PHOSPHORIC ACID SOLUTION, AND THE APPLICATIONS THEREOF | UNIVERSITE DE MONTPELLIER (FR) | 2019-07-18 | — | — | US | claimed |
| US-20180355457-A1 | METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM PRESENT IN AN AQUEOUS SOLUTION INCLUDING PHOSPHORIC ACID | Orano Mining (FR) | 2018-12-13 | — | — | US | claimed |
| US-9441285-B2 | Bifunctional compounds useful as ligands of uranium (VI), methods of synthesising same and uses thereof | AREVA MINES (FR) | 2016-09-13 | — | — | US | claimed |
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | AREVA MINES (FR) | 2015-05-14 | — | — | US | claimed |
| US-11466341-B2 | Extractant for rare earth extraction from aqueous phosphoric acid solutions and method of extraction | Commissariat á l'énergie atomique et aux énergies alternatives (FR) | 2022-10-11 | — | — | US | disclosed |
| WO-2022117948-A1 | METHOD FOR SELECTIVELY RECOVERING RARE EARTH METALS AND URANIUM(VI) FROM AN AQUEOUS SOLUTION OF PHOSPHORIC ACID | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2022-06-09 | — | — | WO | disclosed |
| US-20190218643-A1 | NEW EXTRACTANT, USEFUL FOR EXTRACTING RARE EARTHS FROM AN AQUEOUS PHOSPHORIC ACID SOLUTION, AND THE APPLICATIONS THEREOF | UNIVERSITE DE MONTPELLIER (FR) | 2019-07-18 | — | — | US | disclosed |
| US-20180355457-A1 | METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM PRESENT IN AN AQUEOUS SOLUTION INCLUDING PHOSPHORIC ACID | Orano Mining (FR) | 2018-12-13 | — | — | US | disclosed |
| US-20180187290-A1 | METHOD FOR SEPARATING IRON FROM AN ORGANIC PHASE CONTAINING URANIUM AND METHOD FOR EXTRACTING URANIUM FROM AN AQUEOUS SOLUTION OF MINERAL ACID CONTAINING URANIUM AND IRON | AREVA MINES (FR) | 2018-07-05 | — | — | US | disclosed |
| US-9441285-B2 | Bifunctional compounds useful as ligands of uranium (VI), methods of synthesising same and uses thereof | AREVA MINES (FR) | 2016-09-13 | — | — | US | disclosed |
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | AREVA MINES (FR) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | URB2, CHRM2, C1S | LPAR3 1152/4885LPAR1 1894/4885LPAR2 1444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.